Fig. 4From: Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysisImmune infiltration and tumor mutation analysis. (A) Differences in infiltration of 10 types of immune cells between two CuRA groups. (B) Differences in expression of immune checkpoints gene between the two groups. (C) Tumor mutation characteristics in the high-CuRA group. (D) Tumor mutation characteristics in the low-CuRA groupBack to article page